Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,431
archived clinical trials in
Anemia

ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Long Beach Memorial Medical Center
21
mi
from 91732
Long Beach, CA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Long Beach Memorial Medical Center
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children´s Hospital Los Angeles, Hemophilia Comprehensive Care Center, Division of Pediatric Hematology/Oncology
15
mi
from 91732
Los Angeles, CA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children´s Hospital Los Angeles, Hemophilia Comprehensive Care Center, Division of Pediatric Hematology/Oncology
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Valley Children's Hospital
230
mi
from 91732
Madera, CA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Valley Children's Hospital
230
mi
from 91732
Madera, CA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children'S Hospital of S.W. Florida
2204
mi
from 91732
Fort Myers, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children'S Hospital of S.W. Florida
2204
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
BIODORON
2318
mi
from 91732
Hollywood, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
BIODORON
2318
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Nemours Children's Clinic - Orlando
2184
mi
from 91732
Orlando, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Nemours Children's Clinic - Orlando
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Tampa Children'S Hospital At St. Joes
2133
mi
from 91732
Tampa, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Tampa Children'S Hospital At St. Joes
2133
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Southern Florida
2134
mi
from 91732
Tampa, FL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Southern Florida
2134
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Rush-Presbyterian-St. Luke's Medical Center
1726
mi
from 91732
Chicago, IL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Rush-Presbyterian-St. Luke's Medical Center
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children´s Memorial Hospital
1729
mi
from 91732
Chicago, IL
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children´s Memorial Hospital
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Indiana Hemophilia and Thrombosis Center
1792
mi
from 91732
Indianapolis, IN
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Indiana Hemophilia and Thrombosis Center
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Iowa Hospitals and Clinics, Iowa Regional Hemophilia Center, Department of Pediatrics
1528
mi
from 91732
Iowa City, IA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Iowa Hospitals and Clinics, Iowa Regional Hemophilia Center, Department of Pediatrics
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Tulane University Hospital & Clinic
1655
mi
from 91732
New Orleans, LA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Tulane University Hospital & Clinic
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Johns Hopkins Hospital
2302
mi
from 91732
Baltimore, MD
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Johns Hopkins Hospital
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Michigan Med. Ctr Htc
1931
mi
from 91732
Ann Arbor, MI
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Michigan Med. Ctr Htc
1931
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Henry Ford Hospital
1965
mi
from 91732
Detroit, MI
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Henry Ford Hospital
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
PHS DEVOS CHILDRENS Hospital
1839
mi
from 91732
Grand Rapids, MI
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
PHS DEVOS CHILDRENS Hospital
1839
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Munson Medical Center
1861
mi
from 91732
Traverse City, MI
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Munson Medical Center
1861
mi
from 91732
Traverse City, MI
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
St. Louis Children's Hospital
1569
mi
from 91732
Saint Louis, MO
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
St. Louis Children's Hospital
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Robert Wood Johnson University Hospital
2410
mi
from 91732
New Brunswick, NJ
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Robert Wood Johnson University Hospital
2410
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Ted R. Montoya Hemophilia Treatment Center
649
mi
from 91732
Albuquerque, NM
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Ted R. Montoya Hemophilia Treatment Center
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
North Carolina Baptist Hospital, Hematology/Oncology Medical Center Boulevard
2125
mi
from 91732
Winston-Salem, NC
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
North Carolina Baptist Hospital, Hematology/Oncology Medical Center Boulevard
2125
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Phs Childrens Hosp Med Ctr Akron
2039
mi
from 91732
Akron, OH
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Phs Childrens Hosp Med Ctr Akron
2039
mi
from 91732
Akron, OH
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children´s Hospital Medical Center Pharmacy, Hemophilia Treatment Center
1880
mi
from 91732
Cincinnati, OH
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children´s Hospital Medical Center Pharmacy, Hemophilia Treatment Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Youngstown HTC
2085
mi
from 91732
Youngstown, OH
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Youngstown HTC
2085
mi
from 91732
Youngstown, OH
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Presbyterian Med Ctr
2373
mi
from 91732
Philadelphia, PA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Presbyterian Med Ctr
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
St. Christopher´s Hospital for Children, Section of Hematology/Oncology
2377
mi
from 91732
Philadelphia, PA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
St. Christopher´s Hospital for Children, Section of Hematology/Oncology
2377
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
University of Tennessee Medical Center
1925
mi
from 91732
Knoxville, TN
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
University of Tennessee Medical Center
1925
mi
from 91732
Knoxville, TN
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Phs-So Tx Hemo Ctr-San Antonio
1188
mi
from 91732
San Antonio, TX
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Phs-So Tx Hemo Ctr-San Antonio
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated:  10/19/2017
Children's Hospital of The King's Daughters
2336
mi
from 91732
Norfolk, VA
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Status: Enrolling
Updated: 10/19/2017
Children's Hospital of The King's Daughters
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Osteoporosis and MRI Study in Hemophilia
Bone and Joint Health in an Adult Hemophilia Population
Status: Enrolling
Updated:  10/19/2017
Los Angeles Orthopedic Hospital
15
mi
from 91732
Los Angeles, CA
Osteoporosis and MRI Study in Hemophilia
Bone and Joint Health in an Adult Hemophilia Population
Status: Enrolling
Updated: 10/19/2017
Los Angeles Orthopedic Hospital
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1463
mi
from 91732
Little Rock, AR
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1463
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
2281
mi
from 91732
Washington, D.C.,
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
2281
mi
from 91732
Washington, D.C.,
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1618
mi
from 91732
Peoria, IL
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1618
mi
from 91732
Peoria, IL
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1793
mi
from 91732
Indianapolis, IN
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1528
mi
from 91732
Iowa City, IA
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1655
mi
from 91732
New Orleans, LA
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1932
mi
from 91732
Ann Arbor, MI
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1966
mi
from 91732
Detroit, MI
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
2449
mi
from 91732
New Hyde Park, NY
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
2449
mi
from 91732
New Hyde Park, NY
Click here to add this to my saved trials
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated:  10/19/2017
Clinical Research Facility
2435
mi
from 91732
New York, NY
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A
Status: Enrolling
Updated: 10/19/2017
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials